juvenile ( 2 ,ug of Polybrene per ml. After centrifugation to remove the PHA, lymphocytes were added to 107 HuT 78 cells and cultured in the presence of 64 half-maximal units per ml of human interleukin-2 (IL-2) (Advanced Biotechnologies) for 1 week and then subcultured weekly without IL-2 for up to 12 weeks. For virus isolation from tissue samples, small portions of fresh or frozen tissue were minced, added to HuT 78 cells, and subcultured weekly. The presence of virus in plasma samples was detected by cocultivating 0.5 ml of plasma with HuT 78 cells in the presence of 25 U of preservative-free heparin (Eli Lilly & Co., Indianapolis, Ind.) per ml. Cell culture supernatant fluids were assayed every 2 weeks for reverse transcriptase activity. Then, 7 ml of culture fluid was clarified of cells, the virus was pelleted through a glycerol cushion, and the presence of reverse transcriptase was assayed with synthetic templates as previously described (3) .
Other cells used to detect virus replication included normal human PBL which were grown in the continuous presence of IL-2 after being stimulated for 3 days with PHA (1 [Lg/ml); fresh human PBL (10 x (36, 37) was used in this study. The antibodies were conjugated with fluorescein-5-isothiocyanate (FITC) (13) or with the phycobiliprotein R-phycoerythrin (PE) as previously described (26) . PBL from experimental and control animals were stained with the following combinations of antibodies for two-color analyses, which has the advantage over one-color analysis of increased sensitivity, resolution, and subset definition. The antibody combinations were: (i) PE-anti-CD4 (red) and FITC-anti-pan-leukocyte marker Lp220 were also detected. In addition, these five animals developed antibodies to high-molecular-weight proteins that by analogy to HIV-2 can be assumed to be envelope glycoproteins (Fig.  1) . The wide band present above the p28 major gag protein is the transmembrane protein of SIV/Mne, designated p32E. It is evident from the data in Fig. 1 that M. nemestrina T85056, although viremic (Table 1) , never developed an antibody response. This animal was the first to exhibit clinical symptoms, characterized by weight loss, a cutaneous macular rash, anemia, and diarrhea, and was euthanized while moribund 15 weeks after inoculation. Subsequently, rhesus macaque A85033 died at 66 weeks, pig-tailed macaque F85062 died at 80 weeks, and rhesus A85034 died at 87 weeks postinoculation. As shown in Fig. 1 , the serum examined 1 week before rhesus A85033 died (week 65) showed a loss of p28 and p16 gag antibodies, similar to the results seen in some AIDS patients during the terminal phase of their illness.
The antibody titers to SIV antigens (determined by ELISA) are shown in Fig. 2 . The five macaques that developed an antibody response had titers that ranged from In an attempt to correlate the presence of neutralizing antibodies with the clinical course of the animals, macaque sera were also tested for the ability to neutralize virus. Various dilutions of sera were incubated with 100 TCID (but 105 total particles) of SIV/Mne, and reverse transcriptase activity was measured 2 weeks after cocultivation with normal human PBL (data not shown). Most serum samples tested had low titers of neutralizing activity (45 to 90% inhibition of reverse transcriptase activity at a 1:100 dilution) that correlated approximately with the overall titers shown in Fig. 2 . The sera from macaque T85056, as expected, had no detectable neutralizing activity. SIV/Mne could be readily isolated from the plasma of the antibody-negative macaque (T85056) but not from the plasma of the antibodypositive animals.
Immunologic status of infected animals. The responses of PBL to the mitogens concanavalin A, pokeweed mitogen, and PHA and the percentage of CD4+, CD8+, T-cell, and B-cell subsets were monitored in the inoculated animals and compared with base-line data obtained in age-and sexmatched control animals. The stimulation of PBL obtained from inoculated animals to all three mitogens was the same as that of PBL from control animals until just shortly (1 to 2 weeks) before death, when mitogen responses were markedly depressed to less than 10% of control levels (data not shown). These results might be explained, at least in part, by reduced levels of lymphocyte subsets in these animals (see below).
The percentages of total CD4+, total CD8+, and activated B cells (CD20+ IgD-) were monitored in inoculated and control macaques (Fig. 3) . Control animals monitored longitudinally for 20 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Pathologic changes in SIV-inoculated macaques. The clinical and pathologic findings in the four macaques (two rhesus, two pigtailed) that died after inoculation with SIV/Mne are summarized in Table 2 . All inoculated macaques developed peripheral lymphadenopathy starting at 3 weeks after inoculation that persisted for the remainder of the life of the animal. A macular erythematous skin rash, which was most pronounced in M. nemestrina T85056, started at 1 week after inoculation and lasted approximately 2 months. Rhesus A85037 1 year after inoculation also had a similar rash which lasted for 2 weeks. Although photographs of M. nemestrina and M. mulatta with this rash were not obtained, Fig. 4 shows a characteristic example of the rash from a Macaca fascicularis inoculated with SIV/Mne in a subsequent study. The erythematous areas were confined primarily to the medial aspects of the thigh, the inguinal and lower abdominal area, the medial aspect of the upper arm and the neck.
Shortly after inoculation, the two baboons developed marked peripheral lymphadenopathy which persisted for 8 months. In addition, baboon T84335 developed a macular erythematous rash at 2 weeks which persisted for an additional 5 weeks. Although similar in appearance to the rash seen in the macaques, it was less extensive, involving only the lower abdominal area. As stated previously, no virus was isolated from plasma, PBL, or lymph node biopsies (by cocultivating with HuT 78 cells or human PBL) and no antibodies to SIV/Mne were detected. The baboons remained clinically and immunologically normal and were removed from the study 1 year after inoculation. The first macaque to die, M. nemestrina T85056, had acute peritonitis secondary to severe ulcerative, necrotizing colitis. In addition, there was oral candidiasis and multinucleated giant cells in lymph nodes (Fig. 5) . M. mulatta A85033 revealed marked lymphoid and bone marrow hyperplasia as well as pancreatitis at necropsy, whereas M. nemestrina F85062 had marked lymphoid atrophy and severe interstitial nephritis, tubular necrosis, and focal and segmental glomerulonephritis (Fig. 6) . M. mulatta A85034 died with severe cryptosporidiosis, enteritis, pancreatitis, a gastric adenocarcinoma, and subacute encephalitis similar to that seen in animal T85056. All four macaques exhibited progressive weight loss and anemia (three animals also had accompanying diarrhea) 2 weeks before death.
Immunocytochemistry for viral antigens and virus isolation from tissues obtained at necropsy. Attempts were made to A85034), pancreas (F85062), liver (A85034), and cerebrospinal fluid (F85062). Virus was also isolated from the plasma of T85056 (the only antibody-negative macaque) and therefore not surprisingly from various tissues of that animal (brain, liver, kidney, heart, and lung) that may have had small amounts of plasma present at the time of cocultivation.
Fixed autopsy specimens from these four macaques were screened for the presence of SIV/Mne antigens by ABC immunohistochemistry, using polyclonal antibodies to SIV/ Mne as previously described (43) . Viral antigens were detected in bone marrow endothelial cells (Fig. 7) of the macaque (F85062) from which virus was also isolated from bone marrow and in the pancreatic islet cells of another (Fig.  8) (2, 4) . Except for the encephalitis seen in two of the six inoculated the present study, this was not a promine SIV/Mne inoculation.
All SIV strains, however, produce a wast with secondary infections as contributing cai These infections appear to differ in each prim the New England studies, an overwhelmir infection in multiple tissues, with inclusio necrosis, developed (27) The present studies show that although SIV/Mne is capable of causing a lethal disease in two species of macaques, some of the characteristics of this disease differ from those observed in other recent studies, particularly with respect to neurotropic lesions. These differences may reflect molecular heterogeneity among the various isolates. The SIV strains have recently been shown to be more closely related to HIV-2, the West African isolate, than to HIV-1. For example, the N-terminal portion of the major gag protein p28 of SIV/Mne was initially shown to be 90% identical to HIV-2 (3, 14) but only 58% identical to the same region of HIV-1 (3). A more complete comparison of 125 positively identified amino acids in the gag region of SIV/Mne reveals an 83% identity to the predicted amino acid sequence of HIV-2 gag proteins and 41% identity over this same region for HIV-1 (Henderson et al., in press). These similarities between HIV-2 and the SIV strains also extend to the remainder of the sequenced regions (5, 11) .
The various SIV strains are beginning to be compared with each other. SIV/mac and SIV/agm have been molecularly cloned and sequenced (5, 11) . These two isolates have a greater than 99% amino acid identity. We have used a 7-kilobase fragment of cloned SIV/agm, generously provided by James Mullins (Harvard University), to clone SIV/Mne. A comparison of a 1.5-kilobase sequenced 3' region of SIV/Mne with SIV/mac reveals an approximately 9% difference between these isolates (R. Benveniste and G. Heidecker, submitted for publication). In the sequenced region of the gag genes (125 amino acids), 90% of the SIV/Mne amino acids were identical to predicted residues of SIV mac and SIV/agm (Henderson et al., in press).
SIV strains have been isolated from two African primate species, the African green monkey (Cercopithecus spp.) and the sooty mangabey (Cercocebus atys). In both these African genera, the virus, although present and eliciting an antibody response, causes no apparent disease. The present study shows that baboons, another primate whose habitat is Africa, is resistant to infection by SIV. Although one baboon in the present study developed a transient macular rash after inoculation similar to that reported in macaques infected with SIV/mac (35) , no virus could be isolated. Baboon lymphocytes express CD4 receptors and can be infected in vitro by SIV/mac (21) and SIV/Mne (3) although they produce only low levels of virus. Thus, resistance in vivo to SIV/Mne infection cannot be attributed simply to the inability of baboon lymphocytes to bind and be infected by SIV/Mne. Other factors (genes?) influencing viral replication or host resistance may be present in baboons. Macaques, a species inhabiting Asia, seem to be uniformly susceptible to this class of viruses.
There is no adequate primate model at present for HIV-1-induced disease; although chimpanzees can be infected and seroconverted, no disease has been elicited in these animals. The primate viruses (SIV strains) cause a disease in macaques that is characterized by a rapid onset (less than 16 months) of weight loss, opportunistic infections, and depletion of CD4+ lymphocytes that resembles in various respects AIDS in humans. Given the close homology between SIV and HIV-2, SIV infection of macaques is a valuable model for studying AIDS and its prevention and control.
Of the six macaques inoculated with SIV/Mne, four had died after 15 
